China is the bigger Plant-Based Supplements market: $989 Mn against $224 Mn in 2023, about 4.4 times as large.
India grows faster: 11% a year, against 9.5%. The gap still grows from $765 Mn to $1.8 Bn by 2033.
Clinical research: 3 active trials in China, 0 in India.
| Measure |  China |  India |
|---|---|---|
| Market size, 2023 | $989 Mn | $224 Mn |
| Market size, 2033 projected | $2.5 Bn | $635 Mn |
| Growth a year (CAGR) | 9.5% | 11% |
| Money added, 2023–2033 | $1.5 Bn | $411 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.70 | $0.15 |
| Active clinical trials | 3 | 0 |
| Full report | China report | India report |
Year by year, 2023 to 2033
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Plant-Based Supplements, China or India?
China is the bigger Plant-Based Supplements market: $989 Mn against $224 Mn in 2023, about 4.4 times as large.
Which grows faster in Plant-Based Supplements, China or India?
India grows faster: 11% a year, against 9.5%. The gap still grows from $765 Mn to $1.8 Bn by 2033.
More Plant-Based Supplements comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.